Measuring the effect of drug treatments on primary human CD8+ T cell activation and cytolytic potential

CD8+ T cells are key effector cells in adaptive immune responses against intracellular pathogens and cancer cells. Systemic drug treatments, like chemotherapy, may positively or negatively affect CD8+ T cell function. In this protocol, we describe robust and optimized ex vivo polyclonal activation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Loo Yau, Helen, De Carvalho, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164095/
https://www.ncbi.nlm.nih.gov/pubmed/34095863
http://dx.doi.org/10.1016/j.xpro.2021.100549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164095/
https://www.ncbi.nlm.nih.gov/pubmed/34095863
http://dx.doi.org/10.1016/j.xpro.2021.100549

Ejemplares similares